Please login or sign up to post and edit reviews.
The First $100 Billion Drug - Publication Date |
- Jan 06, 2023
- Episode Duration |
- 00:24:12
BofA analyst Geoff Meacham talks about downgrading Pfizer, upgrading Merck, and what he thinks will become the best selling medicine of all time.
Learn more about your ad choices. Visit
megaphone.fm/adchoicesThis episode could use a review!
This episode could use a review! Have anything to say about it? Share your thoughts using the button below.
Submit Review